Portfolio company
EpiBone
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company grows personalized bone and cartilage grafts from a patient's own stem cells to treat individuals with skeletal defects.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
GreenBone
This company produces rattan wood-derived bone substitutes for adult patients undergoing orthopedic surgery to treat severe bone defects and fractures.
Novadip Biosciences
This company develops regenerative tissue products to treat patients with large bone defects, non-union fractures and spinal fusion requirements.
CartiHeal
This company develops aragonite-based implants for the regeneration of cartilage and bone in patients with traumatic or osteoarthritic joint defects.
CERHUM
This company manufactures 3D-printed bioceramic bone grafts and patient-specific implants for surgeons performing maxillofacial, dental, and orthopaedic reconstructions.
Novadip
This company develops regenerative tissue products to treat large bone defects and spinal fusion for patients with limited treatment options.
Klona Biotech
The company develops 3D-bioprinted structural human tissue implants, such as ligaments and tendons, for healthcare providers and patients requiring reconstructive surgery.
IBI
This company develops and manufactures biomimetic bone substitutes for orthopaedic and dental surgeons to support bone tissue regeneration.
Hyalex Orthopaedics
This company develops synthetic cartilage and implant systems to restore damaged joint surfaces for patients with osteoarthritis or cartilage injuries.